⏳ Fetching live dividend data...
Home › Calculator › AIKI Dividend Calculator 2026
AIkido Pharma Inc. · NASDAQ
Price: $3.56 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in AIKI → $863.5K in 10 years · $25,883.43/month
AIkido Pharma Inc., established in 1967 and headquartered in New York, New York, is a biotechnology company primarily engaged in pioneering small-molecule anti-cancer treatments. The firm, which operated as Spherix Incorporated until its rebranding in March 2021, possesses a robust therapeutic pipeline addressing various malignancies, including prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. Key drug candidates in its development portfolio include DHA-dFdC, targeting pancreatic cancer, and KPC34, a small molecule designed for the treatment of both AML and acute lymphoblastic leukemia. Furthermore, AIkido Pharma Inc. is advancing an antiviral platform engineered to hinder the proliferation of numerous viruses, such as the influenza virus, Ebolavirus, Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. The company holds strategic license agreements with several academic and research institutions, including the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open AIKI position with:
Real after-tax yield depends on where you live and how you hold AIKI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 56.18% | 53.38% | $5,618 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 47.75% | 44.95% | $4,775 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 44.94% | 42.14% | $4,494 / yr |
| 🇬🇧 UK ISA | 0% | 56.18% | 53.38% | $5,618 / yr |
| 🇬🇧 UK Taxable | 8.75% | 51.26% | 48.46% | $5,126 / yr |
| 🇨🇦 TFSA | 0% | 56.18% | 53.38% | $5,618 / yr |
| 🇨🇦 CA Taxable | 25% | 42.13% | 39.34% | $4,214 / yr |
| 🇦🇺 Super (pension) | 15% | 47.75% | 44.95% | $4,775 / yr |
| 🇦🇺 AU Taxable | 30% | 39.33% | 36.53% | $3,933 / yr |
| 🇩🇪 DE Taxable | 26.375% | 41.36% | 38.56% | $4,136 / yr |
| 🇫🇷 FR Taxable | 30% | 39.33% | 36.53% | $3,933 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
AIKI pays quarterly — 4 times per year. Next ex-div: TBD.
How AIKI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AIKI sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2023-12-26 | 7,000 | $2.55 | $17.9K | ||
| Buy | 2023-12-26 | 5,000 | $2.60 | $13.0K | ||
| A-Award | 2023-12-21 | 630,050 | $2.02 | $1.27M | ||
| Buy | 2023-12-20 | 70,000 | $2.00 | $140.2K | ||
| Buy | 2023-12-12 | 2,000 | $2.00 | $4.0K | ||
| Buy | 2023-12-12 | 2,000 | $2.00 | $4.0K | ||
| Buy | 2023-12-12 | 2,000 | $2.04 | $4.1K | ||
| Buy | 2023-12-12 | 2,000 | $2.02 | $4.0K | ||
| Buy | 2023-11-30 | 1,000 | $2.28 | $2.3K | ||
| Buy | 2023-11-28 | 1,000 | $2.26 | $2.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AIKI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
AIkido Pharma Inc. (AIKI) is currently trading at $3.56, trading near its 52-week low. The current dividend yield is 56.18% based on an annual payout of $2.00 per share.
AIkido Pharma Inc. (AIKI) is a healthcare stock currently trading at $3.56 with a dividend yield of 56.18%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever